New directions in the FDA regulation of in vitro diagnostic devices

Citation
S. Gutman et K. Richter, New directions in the FDA regulation of in vitro diagnostic devices, LAB MED, 30(12), 1999, pp. 782-784
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology
Journal title
LABORATORY MEDICINE
ISSN journal
00075027 → ACNP
Volume
30
Issue
12
Year of publication
1999
Pages
782 - 784
Database
ISI
SICI code
0007-5027(199912)30:12<782:NDITFR>2.0.ZU;2-6
Abstract
Since 1976, the Food and Drug Administration has been involved activity in the regulation of in vitro diagnostic devices. Regulation involves a series of premarket and postmarket controls designed to assure that tests meet mi nimum thresholds of performance and are labeled properly. The review progra m for medical devices recently has undergone a variety of changes to produc e more effective use of its regulatory tools.